{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:34:29Z","timestamp":1760150069148,"version":"build-2065373602"},"reference-count":56,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Mastocytosis is a heterogeneous group of rare hematological disorders that can occur in infancy. We report a 16-year-old girl who presented with an aggressive form of systemic congenital mastocytosis, associated with a significant global developmental delay, deafness, and multiple anomalies. At 4 years of age, she developed a germinoma presenting as an invasive spinal mass. Extensive cytogenetic, metabolic, and molecular genetic studies that included whole-exome sequencing studies revealed a KIT alteration (NM_000222.3(KIT):c2447A &gt; 7 pAsp816Val) and likely pathogenic variant in the DNA from peripheral blood and skin lesions. C-kit was also found to be overexpressed in the spinal tumor cells. We compared the features of this child to those of six previously reported pediatric patients with cutaneous mastocytosis, microcephaly, microtia, and\/or hearing loss reported in OMIM as mastocytosis, conductive hearing loss, and microtia (MIM 248910), for which the etiology has not yet been determined. This report extends the currently recognized spectrum of KIT-related disorders and provides clues as to the potential etiology of a syndromic form of congenital mastocytosis. International efforts to understand the benefits of long-term targeted therapy with tyrosine kinase inhibitors for this KIT-altered rare disease should continue to be evaluated in clinical trials.<\/jats:p>","DOI":"10.3390\/curroncol30100649","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T07:28:29Z","timestamp":1696318109000},"page":"8992-9003","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Review of the Clinical Features and Management of Systemic Congenital Mastocytosis through the Presentation of An Unusual Prenatal-Onset Case"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9773-0995","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Larouche","sequence":"first","affiliation":[{"name":"Department of Pediatric Hemato-oncology, Centre Hospitalier Universitaire de Quebec-Universit\u00e9 Laval, Quebec, QC G1V4G2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Fr\u00e9d\u00e9rique","family":"Par\u00e9","sequence":"additional","affiliation":[{"name":"Medecine Faculty, Laval University, Quebec, QC G1V4G2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Olivier","family":"Grenier","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Centre Hospitalier Universitaire de Quebec-Universit\u00e9 Laval, Quebec, QC G1V4G2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Wieckowska","sequence":"additional","affiliation":[{"name":"Departement of Pediatric, Centre Hospitalier Universitaire de Quebec-Universit\u00e9 Laval, Quebec, QC G1V4G2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Gagn\u00e9","sequence":"additional","affiliation":[{"name":"Department of Pathology, Centre Hospitalier Universitaire de Quebec-Universit\u00e9 Laval, Quebec, QC G1V4G2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Laframboise","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre Hospitalier Universitaire de Quebec-Universit\u00e9 Laval, Quebec, QC G1V4G2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-3692","authenticated-orcid":false,"given":"Nada","family":"Jabado","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hemato-Oncology, Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal, QC G1V4G2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"De Bie","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Specialized Medicine, McGill University Health Centre, Montreal, QC G1V4G2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D350W1R5RF","article-title":"Diffuse cutaneous mastocytosis: Report of a severe case with fatal outcome","volume":"17","author":"Ghiasi","year":"2011","journal-title":"Dermatol. Online J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1525-1470.2010.01212.x","article-title":"Neonatal onset diffuse cutaneous mastocytosis: A case report and review of the literature","volume":"28","author":"Koga","year":"2011","journal-title":"Pediatr. Dermatol."},{"key":"ref_3","first-page":"36","article-title":"Systemic mastocytosis with diffuse cutaneous involvement and haematological disease presenting in utero treated unsuccessfully with vincristine","volume":"33","author":"Angus","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000089026","article-title":"Neonatal mastocytosis with pachydermic bullous skin without c-Kit 816 mutation","volume":"212","author":"Walker","year":"2006","journal-title":"Dermatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2003.11.015","article-title":"Congenital cutaneous mastocytosis","volume":"145","author":"Mann","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0929-693X(03)00458-5","article-title":"Systemic infantile mastocytosis: About a case with respiratory and digestive involvement","volume":"10","author":"Chemli","year":"2003","journal-title":"Arch. Pediatr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1046\/j.1365-2141.1999.01683.x","article-title":"Rechavi GC-kit activating mutation in a neonate with in-utero presentation of systemic mastocytosis associated with myeloproliferative disorder","volume":"106","author":"Kuint","year":"1999","journal-title":"Br. J. Haematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Li, Z. (2021). New Insights into the Pathogenesis of Systemic Mastocytosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094900"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated Diagnostic criteria and Classification of Mast Cell Disorders: A Consensus Proposal","volume":"5","author":"Valent","year":"2021","journal-title":"HemaSphere"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/jid.2009.448","article-title":"Mastocytosis in children is associated with mutations in c-KIT","volume":"130","author":"Price","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay","volume":"13","author":"Kristensen","year":"2011","journal-title":"J. Mol. Diagn."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.exphem.2011.05.009","article-title":"Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis","volume":"39","author":"Wasag","year":"2011","journal-title":"Exp. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"373-378","DOI":"10.1016\/j.leukres.2005.08.015","article-title":"A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy","volume":"30","author":"Zhang","year":"2006","journal-title":"Leuk. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1136\/jmg.2003.015156","article-title":"A germline mutation in KIT in familial diffuse cutaneous mastocytosis","volume":"41","author":"Tang","year":"2004","journal-title":"J. Med. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1525-1470.2001.01939.x","article-title":"Familial cutaneous mastocytosis","volume":"18","author":"Chang","year":"2001","journal-title":"Pediatr. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMra1409760","article-title":"Mast Cells, Mastocytosis, and Related Disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4084\/MJHID.2021.069","article-title":"Pediatric Mastocytosis: An Update: Children Mastocytosis","volume":"13","author":"Giona","year":"2021","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ijc.23137","article-title":"Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor","volume":"122","author":"Kleinbaum","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ajmg.a.30388","article-title":"Novel c-KIT germline mutation in a family with gastrointestinal stromal tumors and cutaneous hyperpigmentation","volume":"132","author":"Carballo","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.06.060","article-title":"Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis","volume":"129","author":"Hartmann","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2005.06.009","article-title":"Familial gastrointestinal stromal tumor syndrome: Phenotypic and molecular features in a kindred","volume":"23","author":"Li","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"657-662","DOI":"10.1002\/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D","article-title":"Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa","volume":"92","author":"Beghini","year":"2001","journal-title":"Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MOP.0b013e328355b248","article-title":"Childhood mastocytosis","volume":"24","author":"Torrelo","year":"2012","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/cncr.25794","article-title":"KIT gene mutation and amplification in dysgerminoma of the ovary","volume":"117","author":"Cheng","year":"2011","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/00313020903305852","article-title":"Mediastinal seminoma with multiple KIT gene mutations","volume":"41","author":"Terada","year":"2009","journal-title":"Pathology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-9440(10)63120-3","article-title":"KIT mutations are common in testicular seminomas","volume":"164","author":"Kemmer","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00428-004-1112-3","article-title":"c-KIT codon 816 mutation in a recurrent and metastatic dysgerminoma of a 14-year-old girl: Case study","volume":"445","author":"Pauls","year":"2004","journal-title":"Virchows Arch."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0002-9440(10)65419-3","article-title":"Activating c-kit mutations in human germ cell tumors","volume":"154","author":"Tian","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1365-2133.2012.10816.x","article-title":"Park SN822K c-kit mutation in CD30-positive cutaneous pleomorphic mastocytosis after germ cell tumour of the ovary","volume":"166","author":"Baek","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MPH.0b013e318063ef26","article-title":"Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states","volume":"29","author":"Lee","year":"2007","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2133.2001.04322.x","article-title":"Cutaneous mastocytosis associated with a mixed germ cell tumour of the ovary: Report of a case and review of the literature","volume":"145","author":"Miyagawa","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0046-8177(98)90029-6","article-title":"Systemic mast cell disease associated with primary ovarian mixed malignant germ cell tumor","volume":"29","author":"Teitell","year":"1998","journal-title":"Hum. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2559.1997.5690793.x","article-title":"Systemic mastocytosis following a malignant ovarian germ cell tumour","volume":"30","author":"Stalder","year":"1997","journal-title":"Histopathology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: A consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk. Res."},{"key":"ref_37","first-page":"2270-2273","article-title":"Apparent third patient with cutaneous mastocytosis, microcephaly, conductive hearing loss and microtia","volume":"149","author":"Salpietro","year":"2009","journal-title":"Am. J. Med. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1399-0004.1990.tb03392.x","article-title":"Skin mastocytosis with short stature, conductive hearing loss and microtia: A new syndrome","volume":"37","author":"Wolach","year":"1990","journal-title":"Clin. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00019605-199204000-00003","article-title":"Skin mastocytosis, hearing loss and mental retardation","volume":"1","author":"Hennekam","year":"1992","journal-title":"Clin. Dysmorphol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1468-3083.2000.00018.x","article-title":"Familial mastocytosis associated with neurosensory deafness","volume":"14","author":"Trevisan","year":"2000","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1525-1470.2007.00489.x","article-title":"Congenital mastocytosis associated with neurosensory deafness","volume":"24","author":"Ina","year":"2007","journal-title":"Pediatr. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1525-1470.1999.00116.x","article-title":"Bullous Mastocytosis: A fatal outcome","volume":"16","author":"Murphy","year":"1999","journal-title":"Pediatr. Dermatol."},{"key":"ref_43","first-page":"598855","article-title":"C-kit, a double-edged sword in liver regeneration ads diseases","volume":"2","author":"Wand","year":"2021","journal-title":"Front. Genet."},{"key":"ref_44","first-page":"261","article-title":"Dominant negative and loss of function mutations of the c-kit (mast\/stem cell growth factor receptor) proto-oncogene in human piebaldism","volume":"50","author":"Spritz","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/hmg\/2.9.1499","article-title":"A recurrent deletion in the KIT (mast\/stem cell growth factor receptor) proto-oncogene is a frequent cause of human piebaldism","volume":"9","author":"Spritz","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12185-008-0166-4","article-title":"Advanced mast cell disease: An Italian hematological multicenter experience","volume":"88","author":"Pagano","year":"2008","journal-title":"Int. J. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.21996","article-title":"Imatinib Mesylate in the treatment of systemic mastocytosis","volume":"107","author":"Droogendijk","year":"2006","journal-title":"Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.leukres.2008.12.020","article-title":"Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis","volume":"33","author":"Cortes","year":"2009","journal-title":"Leuk. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"456-458","DOI":"10.1111\/j.1600-0609.2008.01048.x","article-title":"Dasatinib therapy for systemic mastocytosis: Four cases","volume":"80","author":"Purtill","year":"2008","journal-title":"Eur. J. Haematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","article-title":"Phase II study of Dasatinib in Philadelphia chromosome negative acute and chronic myeloid diseases, including systemic mastocytosis","volume":"14","author":"Verstovsek","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/0008-5472.CAN-05-2050","article-title":"Dasatinib (BMS-354825), a dual SRC\/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies","volume":"66","author":"Schittenhelm","year":"2006","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fphar.2015.00300","article-title":"New insight into the anti-liver fibrosis effects of multitargeed tyrosine kinase inhibitors","volume":"6","author":"Qu","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41591-021-01538-9","article-title":"Safety and efficacy of avapritinib in advanced systemic mastocytosis: The phase 1 EXPLORER trial","volume":"27","author":"DeAngelo","year":"2021","journal-title":"Nat. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/s41591-021-01539-8","article-title":"Efficacy and safety of avapritinib in advanced systemic mastocytosis: Interim analysis of the phase 2 PATHFINDER trial","volume":"27","author":"Gotlib","year":"2021","journal-title":"Nat. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajh.26118","article-title":"Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management","volume":"96","author":"Pardanani","year":"2021","journal-title":"Am. J. Hematol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/10\/649\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:04:34Z","timestamp":1760130274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/10\/649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["curroncol30100649"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30100649","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2023,10,3]]}}}